Source: Aldevron Blog

Aldevron Blog Enhancing Process Rigor and Quality in RNP Manufacturing

Webinar Recap: CRISPR Genome Editing Solutions from Discovery to ClinicGene-modified cell therapies have been an area of much focus for drug developers over the last decade in the cell and gene therapy arena. Innovations around CRISPR technology have made it faster and more straightforward than ever before to manufacture patient doses of gene-modified cells.

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
500-1.0K
Jennifer Meade's photo - President of Aldevron

President

Jennifer Meade

CEO Approval Rating

82/100

Read more